Month: June 2024

FLOW kidney outcomes trial data evaluating efficacy and safety of once-weekly semaglutide 1.0 mg in people with type 2 diabetes1 SELECT cardiovascular outcomes trial data evaluating efficacy and safety of once-weekly semaglutide 2.4 mg in people with obesity and established cardiovascular disease, without diabetes2 STEP HFpEF trial programme data evaluating efficacy and safety of once-weekly semaglutide 2.4 mg in people with obesity-related heart failure with preserved ejection fraction (HFpEF), with and without diabetes3,4Bagsværd, Denmark, 18 June 2024 – Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA). The conference will be held in-person and virtually from 21–24 June 2024 in Orlando, US. Additional...

3D Systems EXT 800 Titan Pellet3D Systems adds the cost-effective, space-saving EXT 800 Titan Pellet to its lineup of high-speed industrial pellet extrusion 3D printers.Smaller footprint with lower upfront investment enables broader adoption of industrial EXT platform in existing and new markets Leverages proven high-speed pellet extrusion technology— up to 10x faster and 10x lower costs — cheaper than available filament systems for better ROI Production platform with refined design and open material architecture to cost-effectively address breadth of industrial applicationsROCK HILL, S.C., June 18, 2024 (GLOBE NEWSWIRE) — Today, 3D Systems (NYSE:DDD) announced the latest addition to its industry-leading portfolio of EXT Titan Pellet systems — the EXT 800 Titan Pellet. With a build volume of 800 x 600 x 800 mm, this...

Transformational acquisition expected to close in the second half of 2024 Projected to double Company’s annualized revenue to approximately $28 million LAKEWOOD, N.J., June 18, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance”, “we” or the “Company”) today provided an update on the pending acquisition of Spetner Associates. Ezra Beyman, Chairman and Chief Executive Officer of Reliance Global Group, commented, “We are excited to share that the anticipated impact of the pending Spetner Associates acquisition is surpassing our initial expectations. Spetner’s BenManage voluntary benefit insurance segment has expanded significantly, now covering 85,000 employees—a phenomenal increase from the 45,000 employee lives it covered at the time we first announced the acquisition. While the transaction...

Initial joint project in Fuzhou expected to generate an increase in revenue by more than 50% over next three years SHENZHEN, China, June 18, 2024 (GLOBE NEWSWIRE) — CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (“CDT”), a leading provider of waste treatment systems and services throughout China, announces the signing of a strategic cooperation agreement with a subsidiary of a large state-owned construction group in China. The parent company of the state-owned construction group is among the top 40 in ENR’s 2023 ranking of the world’s largest contractors. Under the terms of the agreement, the two parties will jointly plan and build a number of infrastructure and construction projects in Fuzhou New Area, involving water, sewage treatment, roads, and pipelines, with an estimated value...

Tony Grossi Brings Over 25 Years of Vice President and Director-Level Experience in Beverage and Food Service Sales Strategic Leadership Hire Follows Recent Addition of Vice President of Supply Chain & Co-Manufacturing, Fortifying Executive Team for Significant Sales Uplift Expected in Fiscal Year 2024 and Beyond LOS ANGELES, June 18, 2024 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced the appointment of Tony Grossi as Vice President of Sales. In this role, Tony will leverage his successful experience by spearheading Barfresh’s sales efforts, overseeing all sales efforts including the Companies expanding sales network. Tony Grossi comes to Barfresh with over 25 years of vice president and director-level...

Day One receives exclusive license for development and commercialization of MTX-13 (DAY301), which received IND clearance by the FDA in April 2024 Targets PTK7, highly expressed in broad range of adult and pediatric solid tumors BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a commercial-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it has entered into an exclusive licensing agreement (the Agreement) with MabCare Therapeutics (MabCare) for MTX-13, a novel ADC targeting protein-tyrosine kinase 7 (PTK7). Pursuant to the terms of the Agreement, Day One has exclusive rights to develop, manufacture, and commercialize MTX-13 worldwide, excluding...

BOSTON, June 18, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that on June 17, 2024, the Company granted an aggregate of 5,400 inducement stock options to two new employees, as an inducement material to each individual entering into employment with Elicio in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement stock options were approved by the Compensation Committee of Elicio’s Board of Directors and granted under the Elicio Therapeutics, Inc. 2024 Inducement Incentive Award Plan. Each grant provides for the purchase of shares of Elicio common stock at a price of $7.98 per share, the closing price per share of Elicio common stock as...

Pharmacokinetic study is key step on path to expansion into US market NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it is entering the next phase of its planned 510(k) submission to the FDA. The Company has successfully completed subject screening for its Pharmacokinetic (PK) Study and will begin dosing and sampling study subjects today. INBS’ PK study is a key step towards the Company’s planned 510(k) submission to the FDA during the fourth quarter of this year. FDA clearance is required to show that INBS’ fingerprint drug screening technology is safe and effective and would result in the Company’s ability to enter the substantial...

JILIN CITY, China, June 18, 2024 (GLOBE NEWSWIRE) — Chijet Motor Company, Inc. (Nasdaq: CJET) (the “Company” or “Chijet”), a high-tech enterprise engaged in the development, manufacture, sales, and service of traditional fuel vehicles and new energy vehicles (“NEV”) in China announced that on June 7, The holding subsidiary FAW Jilin Automobile Co., Ltd. (“FAW JiLin”) of Chijet Motor signed an intention agreement with the administration committee of Jilin National High-tech Industrial Development Zone and Haikou BIAOCHI Automobile Culture Development Co., Ltd. (“BIAOCHI”) for automobile industry culture tourism and race automobile R&D and manufacture. FAW JiLin and BIAOCHI will cooperate to do project of automobile culture tourism with northeast ice-snow tourism characteristics. Depending on the automobile R&D and manufacture...

Figure 1Jay Jiang Yu, Executive Chairman and President of NANO Nuclear Energy Inc. alongside Professor Massimiliano Fratoni, Ph.D., Senior Director and Head of Reactor Design, who was awarded the Untermyer & Cisler Reactor Technology Metals at the 2024 Annual Conference Hosted by the American Nuclear Society.Chair of University of California Berkeley Nuclear Engineering Department, NANO Nuclear Energy Head of Reactor Design and ‘ZEUS’ Development Lead, Prof. Massimiliano Fratoni recognized for his excellence in advanced reactor development. New York, N.Y., June 18, 2024 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear”), an emerging vertically integrated microreactor and advanced nuclear technology company led by a world-class nuclear engineering team developing proprietary, portable, and...